Active substances
Amiloride + Hydrochlorothiazide
- SFDA 3
- US FDA 7
- Health Canada 1
- US price lines 1
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| AMURETIC 5MG/50MG TAB | 50,5 mg,mg | Tablet · Oral use | 20 Blister | SAR 8.75 | Generic · Prescription | DAR ALDAWA | Valid |
| MODURETIC 5-50MG TABLETS | 50,5 mg,mg | Tablet · Oral use | 30 Blister | SAR 17.60 | Generic · Prescription | Algorithm SAL | Suspended |
| APO-AMILZIDE | 5, 50 mg | Tablet · Oral use | 30 Blister | SAR 15.80 | Generic · Prescription | APOTEX | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
CONGESTIVE HEART FAILURE; HYPERTENSION; PULMONARY ARTERIAL HYPERTENSION
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | EQ 5MG ANHYDROUS;50MG | tablet · oral | BARR | Prescription | 10 May 1988 |
| AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | EQ 5MG ANHYDROUS;50MG | tablet · oral | RISING | Prescription | 31 Oct 1991 |
| MODURETIC 5-50 | EQ 5MG ANHYDROUS;50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | MERCK | Discontinued | 5 Oct 1981 |
| HYDRO-RIDE | EQ 5MG ANHYDROUS;50MG | tablet · oral | PAR PHARM | Discontinued | 6 Aug 1986 |
| AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | EQ 5MG ANHYDROUS;50MG | tablet · oral | TEVA | Discontinued | 15 Jul 1987 |
| AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | EQ 5MG ANHYDROUS;50MG | tablet · oral | WATSON LABS | Discontinued | 19 Jul 1991 |
| AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | EQ 5MG ANHYDROUS;50MG | tablet · oral | CHARTWELL RX | Discontinued | 27 Nov 1991 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| AA-AMILZIDE | 00784400 | 5 MG; 50 MG | TABLET · ORAL | AA PHARMA INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB | $0.44985 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Co-amilozide 2.5mg/25mg tablets | £92.17 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Co-amilozide 5mg/50mg tablets | £28.35 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.